Baird Downgrades Regeneron Pharma (REGN) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Regeneron (REGN) Climbs Following Upgarde
February 27, 2020 8:59 AM ESTRegeneron (NASDAQ: REGN) climbed Thursday, adding to recent gains, after it was upgraded at Barclays to Overweight. Shares were up 4.15%.
... MorePiper Sandler Reiterates Overweight Rating on Regeneron Pharma (REGN), is 'Incrementally Positive'
February 25, 2020 9:47 AM ESTPiper Sandler analyst Christopher Raymond reiterated an Overweight rating and $435.00 price target on Regeneron Pharma (NASDAQ: REGN)
The analyst comments "Incrementally positive on REGN shares after learning that ASRS issued a member communication entitled Beovu Update last night that we think meaningfully... More
Regeneron (REGN) Climbs Following Three Analyst Updates
February 25, 2020 9:39 AM ESTRegeneron (NASDAQ: REGN) gained Tuesday after it was upgraded to Outperform at Bernstein and Evercore ISI and Buy at Jefferies. Shares climbed 4.5%.
... MoreBernstein Upgrades Regeneron Pharma (REGN) to Outperform
February 25, 2020 7:52 AM ESTBernstein upgraded Regeneron Pharma (NASDAQ: REGN) from Market Perform to Outperform.
For an analyst ratings summary and ratings history on Regeneron Pharma click here. For more ratings news on Regeneron Pharma click here.
Shares of Regeneron Pharma closed at $432.27 yesterday.
... MoreJefferies Upgrades Regeneron Pharma (REGN) to Buy
February 25, 2020 4:39 AM ESTJefferies analyst Biren Amin upgraded Regeneron Pharma (NASDAQ: REGN) from Hold to Buy with a price target of $492.00.
For an analyst ratings summary and ratings history on Regeneron Pharma click here. For more ratings news on Regeneron Pharma click here.
Shares of Regeneron Pharma closed at $425.38 yesterday.
... MoreEvercore ISI Upgrades Regeneron Pharma (REGN) to Outperform 'as Beovu Stumble Looks Real'
February 24, 2020 4:21 PM ESTEvercore ISI analyst Dr. Josh Schimmer upgraded Regeneron Pharma (NASDAQ: REGN) from In Line to Outperform.
For an analyst ratings summary and ratings history on Regeneron Pharma click here. For more ratings news on Regeneron Pharma click here.
Shares of Regeneron Pharma closed at $403.15 yesterday.
... MoreRegeneron (REGN) Trades at High, Up 2.8%
February 24, 2020 12:20 PM ESTRegeneron (NASDAQ: REGN) Trades at High, Up 2.8%
